Toll-Like Receptor 9 Agonists Promote Cellular Invasion by Increasing Matrix Metalloproteinase Activity
Joanna Ilvesaro, Bradley Gehrs
Molecular Cancer Research, 2006
View PDFchevron_right
Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9
Ihsan Gursel
Seminars in Immunology, 2004
View PDFchevron_right
Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells
Ihsan Gursel
The Journal of Immunology, 2001
View PDFchevron_right
Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction
Atie Suwarti
Biochemical and biophysical research communications, 2013
View PDFchevron_right
Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation
Paul J Payette
Immunology, 2004
View PDFchevron_right
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro
Joanna Ilvesaro
The Prostate, 2007
View PDFchevron_right
Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity
Klaus Heeg
Immunology, 2008
View PDFchevron_right
Activation of Human Cells Receptor 9 in CpG DNA-Induced Cutting Edge: Role of Toll-Like
Ihsan Gursel
2000
View PDFchevron_right
Human lung cancer cells express functionally active Toll-like receptor 9
Torsten Goldmann
Respiratory Research, 2005
View PDFchevron_right
CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo
Andreas Hoeft
Respiratory Research, 2007
View PDFchevron_right
The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating In Vivo Inflammatory Responses to Select CpG and Non-CpG Oligonucleotides
Suzanne Paz
Nucleic acid therapeutics, 2017
View PDFchevron_right
Modifications Incorporated in CpG Motifs of Oligodeoxynucleotides Lead to Antagonist Activity of Toll-like Receptors 7 and 9
Fugang Zhu
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
Interaction of CpG-oligodeoxynucleotides with Toll like receptor 9 induces apoptosis and modulates metaloproteinase-2 activity in human intestinal epithelium
mohammad pezeshki
Iranian journal of allergy, asthma, and immunology, 2007
View PDFchevron_right
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway
Louis Boon
Nature Communications, 2013
View PDFchevron_right
Phosphorothioate-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for Toll-like receptor 9 in receptor revision
Klaus Heeg
Immunology, 2013
View PDFchevron_right
Toll-Like Receptor 9-Independent Suppression of Skin Inflammation by Oligonucleotides
Andor Pivarcsi
Journal of Investigative Dermatology, 2007
View PDFchevron_right
Ligand-induced conformational changes allosterically activate Toll-like receptor 9
anjali verma
Nature Immunology, 2007
View PDFchevron_right
Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications
Mallikarjuna Putta
2006
View PDFchevron_right
Nucleic Acids Exert a Sequence-independent Cooperative Effect on Sequence-dependent Activation of Toll-like Receptor 9
Philip Griebel
Journal of Biological Chemistry, 2007
View PDFchevron_right
Immune-Stimulatory Dinucleotide at the 5′-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses
Mallikarjuna Putta
ACS Medicinal Chemistry Letters, 2013
View PDFchevron_right
Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells
Veronika Bachanova
Blood, 2010
View PDFchevron_right
Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9
Jeng-fan Lo
Comparative Immunology, Microbiology and Infectious Diseases, 2012
View PDFchevron_right
Non-CpG-Containing Antisense 2′-Methoxyethyl Oligonucleotides Activate a Proinflammatory Response Independent of Toll-Like Receptor 9 or Myeloid Differentiation Factor 88
Sebastien Burel
Journal of Pharmacology and Experimental Therapeutics, 2005
View PDFchevron_right
Phase II Trial of a Toll-Like Receptor 9-Activating Oligonucleotide in Patients With Metastatic Melanoma
Arthur Krieg
Journal of Clinical Oncology, 2006
View PDFchevron_right
Immunomodulatory oligonucleotides containing a cytosine-phosphate-2���-deoxy-7-deazaguanosine motif as potent Toll-like receptor 9 agonists
daqing wang
2005
View PDFchevron_right
IN VIVO EFFECT OF CPG OLIGODEOXYNUCLEOTIDES (CPG ODNS) ON THE EXPRESSION OF TOLL-LIKE RECEPTOR9 (TLR9) IN CATLA CATLA
Uma Arumugam
View PDFchevron_right
CpG oligodeoxynucleotides induce IL-8 expression in CD34+ cells via mitogen-activated protein kinase-dependent and NF- B-independent pathways
Myung-Ju Ahn
International Immunology, 2005
View PDFchevron_right
Amphotericin B abolishes the cytotoxic effect of Toll-like receptor 9 agonist CpG Oligonucleotides in breast cancer cell line MCF-7
Venil N Sumantran
National Journal of Physiology, Pharmacy and Pharmacology
View PDFchevron_right